Results 261 to 270 of about 238,870 (356)

MCV/Q, Medical College of Virginia Quarterly, Vol. 16 No. 1 [PDF]

, 1980

core   +1 more source

The Demographics and Outcomes of Women With Stage II Endometrial Cancer Diagnosed in Australia 2005–2007

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Stage II endometrial cancer comprises 5% to 10% of cases and is pathologically diverse. Retrospective data guides recommendations which suggest surgical staging with adjuvant therapy, but the role of radical surgery and lymphadenectomy is uncertain, due to conflicting outcomes.
Jonathan Sandeford, Pearl Tong, Selvan Pather   +2 more
wiley   +1 more source

A nomogram for the prediction of endometrial cancer in postmenopausal women with a thickened endometrium. [PDF]

BMC Womens Health
Ai F, Zhu H, Wang C, Zhou L, Wang S.
europepmc   +1 more source

Before the Burn: Predicting Endometrial Ablation Failure

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background While endometrial ablation (EA) offers a minimally invasive alternative to a hysterectomy for women suffering from abnormal uterine bleeding (AUB), clinicians currently lack reliable predictive tools to identify which patients will experience treatment failure, leaving both providers and patients to make treatment decisions with ...
Anne Woolfield, Jessica Phillips, Ian Hughes, Kristen Jones, Rhys Harris, Sally Byford, Graeme Walker   +6 more
wiley   +1 more source

SEOM-GEICO clinical guidelines on endometrial cancer (2025). [PDF]

Clin Transl Oncol
Ramírez SP, Fidalgo AP, Ginesta MPB, De Juan Ferré A, Madrid LF, Martínez AG, Montosa FG, Madariaga A, Gómez TM, Gil-Martin M.   +9 more
europepmc   +1 more source

A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis‐Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Although there is growing evidence supporting the use of cannabis‐based medicinal products (CBMPs) for the management of chronic pain, there is a paucity of data on their effect on endometriosis‐associated chronic pain. Aims This study aimed to perform an analysis of pain‐specific and general health‐related quality of life (HRQoL ...
Sara Getter, Simon Erridge, John Warner‐Levy, Evonne Clarke, Katy McLachlan, Ross Coomber, Shelley Barnes, Alia Darweish Medniuk, Rahul Guru, Wendy Holden, Mohammed Sajad, Robert Searle, Azfer Usmani, Sanjay Varma, James J. Rucker, Michael Platt, Mikael H. Sodergren   +16 more
wiley   +1 more source

The role of reactive oxygen species in the pathogenesis and treatment of endometrial cancer. [PDF]

Front Med (Lausanne)
Lee J, Yeo SG, Lee JM, Kim SS, Jeong YJ, In Oh T, Park DC.   +6 more
europepmc   +1 more source

A Scoping Systematic Review of Cannabis Use in Endometriosis

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Endometriosis, affecting 6%–10% of reproductive‐age women, causes chronic pelvic pain, dysmenorrhea, and infertility. Current treatments have limitations and consequently there is rising interest in effects of cannabis on pain and inflammation associated with endometriosis.
Kindha McLaren, Simon Erridge, Mikael H. Sodergren   +2 more
wiley   +1 more source

Diagnostic and prognostic potential of microRNA profiles in endometrioid endometrial cancer. [PDF]

Sci Rep
Soykan Y, Yar Saglam AS, Inan MA, Ugras Dikmen A, Erdem Ö, Onan MA.   +5 more
europepmc   +1 more source

Exploring endometrial cancer in premenopausal women—A nationwide PremEnCa cohort study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Almost half of the cohort of EC in women ≤50 has obesity and the prognosis is generally excellent. Non‐endometrioid histology and advanced tumor stage were the strongest negative prognostic factors. Half of the deaths were due to non‐cancer causes, emphasizing the need for a focus on overall health.
Chrysanthos Ioannou, Cecilia Malmsten, Per Ehn, Erik Holmberg, Pernilla Dahm‐Kähler, Karin Stålberg   +5 more
wiley   +1 more source